Costco takes on healthcare, though differently from other retailers

The latest stories trending on MedCity News.

Editor's Pick

Top Story Costco Takes On Healthcare, Though Differently From Other Retailers, Experts Say Costco is partnering with Sesame to offer Costco Members discounted pricing on virtual health services, including primary care and mental health. But the move is a little different from other retailers like CVS Health and Walgreens. Sponsored Content Remote Patient Monitoring: Gaining Insight into Patient Health from Afar Presented by Greenway Health The era of remote patient monitoring is ushering in a new era of healthcare, characterized by data-driven insights, personalized care, and efficient resource utilization. Learn More>> Please Tell Us What You Think If you haven't already - You still have time to provide us feedback on what works for you and what doesn't on MedCity News. Please take a few moments to share your thoughts. At the end of the survey, you can enter to win a $250 gift card. Thank you. Take Survey Now

Featured News

Cartwheel Snags $20M For School-based Mental Health Services Cartwheel, a startup that partners with school districts to provide virtual mental health services, raised $20 million in Series A funds. The company is working with about 50 school districts and charter school networks across Massachusetts, Illinois, New York, Rhode Island and Connecticut. Ionis Posts Trial Data in Rare Disease That Position It to Finally Set Out on Its Own Ionis Pharmaceuticals' olezarsen has Phase 3 results showing the therapy handily beat a placebo at reducing fat levels in the blood due to a rare, inherited metabolic disorder with no FDA-approved drugs. Ionis plans early 2024 submissions for what could become the first medicine it commercializes without a partner. CMS: MA Premiums To Remain the Same for Most Beneficiaries in 2024 The average monthly plan premium for Medicare Advantage is expected to increase only slightly in 2024 from 2023, CMS said. About 73% of beneficiaries will see no increase at all. After NASH Hopes Are Dashed, Intercept Pharma Agrees to $794M Buyout Intercept Pharmaceuticals' acquisition by Alfasigma comes three months after the FDA again rejected the biotech's drug as a treatment for the fatty liver disease NASH. But Intercept still has rare liver disease assets, and Italy-based Alfasigma says acquiring the company will help it expand in gastroenterology and hepatology. Intermountain CEO: You Don't Have To Be a Payvider to Reach Scale in VBC The advancement of value-based care cannot and should not exist solely in a payvider model, Intermountain Health CEO Rob Allen argued in an interview last week. Having its own health plan made things "a little easier" when Intermountain began getting serious about at-risk contracts, but achieving success in value-based care "is more about your commitment to the approach" and forging strong relationships with payers of all types. MedCity Pivot Podcast: Tackling Rare Disease With Someone Who Was Touched By It Rich Horgan believes that there's an alternative path to drug development that can lower costs and the time it takes to bring drugs to market. He is trying to apply it to the field of rare and ultra-rare diseases.

Resources

Introducing MedCity FemFwd, a New Podcast on Women's Health In the inaugural episode of the MedCity FemFwd podcast, Michelle Long, senior policy analyst for the Women's Health Policy program at KFF, talks about Opill, which recently made headlines as the first daily oral contraceptive approved for nonprescription use in the U.S. Long tells listeners why this news is significant and examines whether the medication will be covered by insurance. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe